1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Joy Hu
Joy Hu
Articles (279) 

Weekly CEO Buys Highlight

Details the CEO buys this past week for the following companies: G-III Apparel Group, W&T Offshore, HealthEquity, DXC Technology and OPKO Health

July 21, 2019 | About:

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

G-III Apparel Group CEO bought 40,000 shares

G-III Apparel Group Ltd. (NASDAQ:GIII) CEO and 10% Owner Morris Goldfarb bought 40,000 shares on July 11 at a price of $26.47. The price of the stock has increased by 3.06% since.

G-III Apparel Group makes a wide range of apparel, footwear, and accessories that it sells under its own brands, licensed brands, and private-label brands. Licenses are core to the company's business and come from well-known apparel brands, professional sports leagues, and over 100 colleges and universities. Most of the company's sales are to department stores, but the company also operates retail stores for some of its proprietary brands, such as Wilson's Leather and G.H. Bass. Other proprietary brands include Andrew Marc, Marc New York, Jessica Howard, Eliza J, and Black Rivet. The company has a market cap of $1.34 billion. Its shares traded at $27.28 with a price-earnings ratio of 9.77 as of July 19.

Net income for the first quarter of fiscal 2020 was $12.0 million compared to $9.9 million in the prior year’s comparable period.

W&T Offshore CEO bought 200,300 shares

W&T Offshore Inc. (NYSE:WTI) Chairman, CEO, President, and 10% Owner Tracy W. Krohn bought 200,300 shares during the past week at the average price of $4.63.

W&T Offshore is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of the company's revenue, with natural gas accounting for a much smaller portion. The company has a market cap of $679.311 million. Its shares traded at $4.83 with a price-earnings ratio of 4.09 as of July 19.

Net loss for the first quarter of 2019 was $47.8 million compared to a net income of $27.6 million for the comparable period of 2018.

Krohn bought 15,000 shares on July 10 at a price of $4.65; 100,300 shares on July 11 at a price of $4.66; and 100,000 shares on July 12 at a price of $4.6. The price of the stock has increased by 5% since.

HealthEquity CEO bought 10,000 shares

HealthEquity Inc. (NASDAQ:HQY) President and CEO Jon Kessler bought 10,000 shares on July 12 at a price of $61.00. The price of the stock has increased by 29.8% since.

HealthEquity provides solutions that allow consumers to make healthcare saving and spending decisions. Its technology allows customers to see their tax-advantaged healthcare savings, compare treatment options and pricing, pay healthcare bills, receive benefit information, and earn wellness incentives. The firm primarily partners with health plans and employers and serves as the custodian of its customers' health savings accounts (HSAs). HealthEquity also engages in reimbursement arrangements and offers healthcare incentives to its members. In addition, the company provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States. The company has a market cap of $4.97 billion. Its shares traded at $79.18 with a price-earnings ratio of 54.16 as of July 19.

Net income for the first quarter ended April 30, 2019 was $41.8 million compared to $22.6 million in the prior-year quarter.

Founder and Vice Chairman Stephen Neeleman bought 10,000 shares on July 12 at a price of $61. The price of the stock has increased by 29.8% since.

Director Robert W. Selander bought 10,000 shares on July 12 at a price of $61. The price of the stock has increased by 29.8% since.

Director Adrian T. Dillon bought 10,000 shares on July 12 at a price of $61. The price of the stock has increased by 29.8% since.

Director Frank Corvino sold 9,524 shares on July 12 at a price of $70.86. The price of the stock has increased by 11.74% since.

Executive Vice President of Operations Angelique Christine Hill sold 9,500 shares on July 12 at a price of $71.4. The price of the stock has increased by 10.9% since.

DXC Technology CEO bought 4,166 shares

DXC Technology Co. (NYSE:DXC) President and CEO John M. Lawrie bought 4,166 shares on July 18 at a price of $56.26. The price of the stock has decreased by 0.59% since.

DXC Technology is a vendor-independent IT services provider that started trading in April 2017. DXC was created via the amalgamation of Computer Sciences Corporation, or CSC, and Hewlett Packard Enterprise's Services business. The combined company has enviable global scale, with annual revenue of around $25 billion, over 170,000 employees, operations across 70 countries, and broad industry exposure. In addition, the firm has roughly 6,000 clients, of which over 200 are within the Fortune 500. The company has a market cap of $14.90 billion. Its shares traded at $55.93 with a price-earnings ratio of 12.50 as of July 19.

Net income was $1.26 billion for fiscal 2019 compared with $1.78 billion in the prior year period.

OPKO Health CEO bought 100,000 shares

OPKO Health Inc. (NASDAQ:OPK) CEO, Chairman, and 10% Owner Phillip Frost bought 100,000 shares during the past week at the average price of $2.14.

OPKO Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. The company’s diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. OPKO Health also owns a specialty active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. The company has a market cap of $1.27 billion. Its shares traded at $2.07 as of July 19.

Net loss for the first quarter of 2019 was $80.8 million compared with a net loss of $43.1 million for the comparable period of 2018.

Frost bought 100,000 shares on June 25 at a price of $2.01; 50,000 shares on July 2 at a price of $2.42; 100,000 shares on July 8 at a price of $2.23; 50,000 shares on July 12 at a price of $2.16; and 50,000 shares on July 16 at a price of $2.12. The price of the stock has decreased by 2.36% since.

For the complete list of stocks bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 5.0/5 (1 vote)

Voters:

Comments

Please leave your comment:


Performances of the stocks mentioned by Joy Hu


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK